It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
weather icon

26

M/CLEAR

TOKYO (5 a.m.)

TODAY'S PRINT EDITION

The Japan Times The Japan Times

Moderna

  • Login
  • SUBSCRIBE
  • My Account
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Skin rash more common in women after Moderna shot, Japan study finds

National Jun 3, 2022

Skin rash more common in women after Moderna shot, Japan study finds

by Tomoko Otake

Swelling, pain and/or itchiness of the arm that received the vaccine was also more common among people in their 30s through 60s.

We need better COVID-19 booster shots, not more of the same

Commentary / World Apr 11, 2022

We need better COVID-19 booster shots, not more of the same

by Faye Flam

There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.

With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition

Business / Corporate Mar 23, 2022

With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition

by Rocky Swift

The U.S. firm is seeking to build on its newfound renown in COVID-19 vaccines and wrestle market share from compatriot Pfizer Inc.

Fourth COVID shot provides little benefit against omicron, study shows

World / Science & Health Mar 17, 2022

Fourth COVID shot provides little benefit against omicron, study shows

The study took place when spread of the omicron variant was rife in Israel, and it found that the fourth dose didn't confer much added protection against infection.

Japan's booster rollout is relying on Pfizer and Moderna. How do the shots compare?

National Feb 7, 2022

Japan's booster rollout is relying on Pfizer and Moderna. How do the shots compare?

by Osamu Tsukimori

Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.

Moderna starts trial for omicron-specific booster shot

World Jan 27, 2022

Moderna starts trial for omicron-specific booster shot

The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.

The decades of discoveries before the ‘miraculous’ sprint to a vaccine

World / Science & Health Jan 16, 2022

The decades of discoveries before the ‘miraculous’ sprint to a vaccine

by Gina Kolata and Benjamin Mueller

The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.

Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate

World / Science & Health Jan 11, 2022

Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate

by Low De Wei

While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac’s and Sinopharm Group’s shots, which have been widely used in the developing world.

The ins and outs of Japan's COVID-19 booster shot rollout

National | EXPLAINER Jan 6, 2022

The ins and outs of Japan's COVID-19 booster shot rollout

by Osamu Tsukimori

Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?

Moderna says its booster dose appears protective against omicron

World / Science & Health Dec 20, 2021

Moderna says its booster dose appears protective against omicron

The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.

Kishida asks Pfizer to expedite supply of further vaccines to Japan

National Dec 17, 2021

Kishida asks Pfizer to expedite supply of further vaccines to Japan

Japan is looking to move up the third round of shots by revising the planned eight-month interval between second jabs and boosters.

Moderna to produce millions of mRNA vaccines in Australia

Business Dec 14, 2021

Moderna to produce millions of mRNA vaccines in Australia

The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats.

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Japan prepares for bounce in tourism, but pre-pandemic demand still far off
    Skiers in Niseko in Hokkaido in 2017
  • Japan firms that embraced remote work rediscover value of the office
    Fujitsu Ltd.'s renewed office in Kawasaki
  • Despite official nudges, Japanese still not unmasking outside
    Most people wear masks even under sweltering heat in Tokyo on Monday.
  • Sony's next big thing in tech is helping Honda take on Tesla
    Kenichiro Yoshida presents the Sony Vision-S electric concept in Las Vegas in 2020.
  • After support for Ukraine, Kishida aims for NATO unity on China
    Group of Seven leaders, including Prime Minister Fumio Kishida, take their seats as Ukrainian President Volodymyr Zelenskyy addresses them via video link during a working session of the G7 summit on Monday at Elmau Castle in southern Germany.
  • BOJ's public relations crisis forces rethink on inflation message

    Thumbnail image
  • Launch of new carrier highlights China's bid to tip balance in the Pacific

    Thumbnail image
  • Crypto crash threatens North Korea's stolen funds as it ramps up weapons tests

    Thumbnail image
  • Trump’s Jan. 6 rage gets vivid retelling in ex-aide’s testimony

    Thumbnail image
  • Abortion legal and apolitical in Japan, but cost and consent present barriers

    Thumbnail image

PODCAST

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Study in Japan JT for Women JT Bookclub Japanese School Directory The Japan Times Jobs
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Support
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times